Roy Winston, Chief Clinical Officer at Pacira BioSciences, Inc. (PCRX), sold 43,248 shares at $72.12 ($3.1M) on 2021-03-31, disclosed to the SEC on 2021-04-02.
Open-market sale of $3.1M PCRX by Chief Clinical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.36 | 16,363 | $1.2M | 37.7% |
| 2 | $70.36 | 16,363 | $1.2M | 37.7% |
| 3 | $71.09 | 4,661 | $331K | 10.9% |
| 4 | $71.09 | 4,661 | $331K | 10.9% |
| 5 | $72.12 | 1,200 | $87K | 2.8% |
| Total | $70.57 avg | 43,248 |
| $3.1M |
| 100% |
| Filing → |
| PCRX | SELL | 2022-08-05 | $27K | — | Filing → |
| PCRX | SELL | 2022-06-08 | $1.9M | — | Filing → |
| PCRX | SELL | 2021-06-08 | $278K | — | Filing → |